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Abstract
Mo«ssbauer spectra of 12 L-thalassemia/hemoglobin E spleen samples from Thai patients who had not received multiple
blood transfusions and chelation therapy and seven L-thalassemia spleen samples from Australian patients who had received
multiple blood transfusions and chelation therapy were recorded with sample temperatures of 78 K. Each spectrum was
found to consist of a superposition of a relatively intense central doublet characteristic of high-spin Fe(III), a low intensity
sextet of peaks due to magnetic hyperfine-field splitting, and occasionally a doublet that could be attributed to heme iron. A
significant (P = 0.01) difference (Kolmogorov-Smirnov statistic of 0.71) between the distributions of sextet signal intensity as
a fraction (Fs) of the total non-heme iron Mo«ssbauer spectral signal for the two groups of patients was detected. The
distribution of Fs for the Thai L-thalassemia/hemoglobin E spleens had a mean value of 0.128 (S.D. 0.035) while that for the
Australian L-thalassemia spleens had a mean of 0.27 (S.D. 0.12). No significant difference between the distributions of non-
heme iron concentrations in the tissues for the two groups of patients was detected by atomic absorption spectrometry. This
study shows that the Australian L-thalassemia patients had a higher fraction of their non-heme spleen iron in a goethite-like
form than the Thai L-thalassemia/Hb E patients. z 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Diseases such as the thalassemias and genetic he-
mochromatosis are examples of iron overload dis-
eases. In the case of hemochromatosis the iron over-
load is a primary symptom of the disease in that
there is a genetic defect [1,2] resulting in a loss of
control of iron absorption from the diet. Once diag-
nosed, the disease can be e¡ectively treated by regu-
lar phlebotomy to remove iron. In the case of tha-
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lassemia, there is a genetic defect resulting in ine¡ec-
tive synthesis of hemoglobin leading to anemia [3].
The anemia, if left untreated, leads to increased er-
ythropoiesis and increased absorption of iron from
the diet [4]. The increased iron absorption results in
iron overload. Most cases of thalassemia major in
wealthy countries are treated with regular red cell
transfusions (to alleviate the anemia). The blood
transfusions result in normal rates of erythropoiesis
and iron absorption from the diet but in themselves
constitute a large in£ux of iron to the body. Thus,
iron chelation therapy is normally administered in
conjunction with red cell transfusion therapy. In
less wealthy countries, however, thalassemic patients
may receive few, if any, blood transfusions and no
chelation therapy.
In both thalassemia and hemochromatosis, excess
iron is deposited in the tissues in the form of ultra¢ne
particles of iron(III) oxyhydroxide [5]. At low levels
of loading, the iron(III) oxyhydroxide particles are
mostly found within the iron storage protein, ferritin.
Ferritin is an approximately spherical molecule with
a central cavity within which the iron(III) oxyhy-
droxide particle is held [6]. The diameter of the cavity
is about 8 nm. The protein shell, which is approx. 2
nm thick, renders the particle water soluble. At high-
er levels of iron loading, iron(III) oxyhydroxide par-
ticles are mostly found in insoluble aggregates asso-
ciated with protein residues. This form of deposit
is known as hemosiderin [7]. High levels of iron de-
posits are toxic to the cell, causing cell damage
through reactions such as catalysis of lipid peroxida-
tion.
The structures of the mineral particles within
mammalian ferritins have been found to be based
on that of the mineral ferrihydrite (5Fe2O3W9H2O)
[8] with variations in the degree of crystallinity and
particle size being observed for ferritins from di¡er-
ent human organs and disease states [9]. However,
three quite di¡erent iron(III) oxyhydroxide mineral
structures have been identi¢ed in hemosiderins from
di¡erent human tissues in several case studies [5,10^
12]. The three di¡erent structures are similar to (i)
the mineral ferrihydrite, (ii) a highly defect and
poorly crystalline goethite (K-FeOOH), and (iii)
non-crystalline hydrated iron(III) oxyhydroxides.
Preliminary studies have suggested that there may
be relationships between the mineral form of the
iron(III) oxyhydroxide particles of hemosiderin and
the type of disease and/or the clinical treatment ad-
ministered to the patient [5,10,11,13^15]. However,
insu⁄cient numbers of patients in these case studies
prevented con¢dent conclusions being drawn about
such relationships. In fact, a more recent study has
questioned the validity of the proposed relationships
[12] based on two further case studies. Thus the ques-
tion of whether the mineral structure of hemosiderin
iron deposits is determined by the type of disease, the
clinical treatment administered, or some other factor
has still not been satisfactorily answered. The present
study aims to elucidate these questions by studying
the form of iron(III) oxyhydroxide deposits in a
relatively large number of patients from two quite
distinct and identi¢able groups, namely (i) seven
Australian L-thalassemic patients who have received
multiple transfusions of packed red cells and
regular chelation therapy and (ii) 12 Thai L-thalasse-
mia/hemoglobin E patients who have received few,
if any, red cell transfusions and no chelation ther-
apy.
2. Materials and methods
Samples of spleen were obtained from seven Aus-
tralian L-thalassemic patients who had undergone
splenectomy at Princess Margaret Hospital, Perth.
The L-thalassemia trait was determined by typing
of the hemoglobin using electrophoresis in combina-
tion with standard hematological techniques. The
ages of the patients at the time of splenectomy
ranged from 10 to 15 years and all had received
regular transfusions of packed red cells together
with chelation therapy. Regular transfusions of
packed red cells (15^20 ml/kg body mass/month)
were started at about 12 months of age. This is
equivalent to a rate of approx. 0.5 units of packed
red cells per month at age 1 year increasing to 1^2
units of packed cells per month by the age of approx.
10 years. Chelation therapy using desferrioxamine
(Desferral, Ciba-Geigy) was started between the
ages of 2 and 3 years. Samples of spleen, liver and
pancreas were also obtained either post splenectomy
or post mortem from 12 Thai L-thalassemia/hemo-
globin E patients from Siriraj Hospital, Bangkok.
The L-thalassemia/hemoglobin E trait was also deter-
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mined by typing of the hemoglobin using electropho-
resis in combination with standard hematological
techniques. The age of the patients ranged from 20
to 40 years and they had received few (less than a
total of 30 units of packed red cells), if any, red cell
transfusions and no chelation therapy.
Tissue samples were freeze dried and ground to a
powder prior to iron content analysis with atomic
absorption spectrometry and Mo«ssbauer spectros-
copy.
Mo«ssbauer spectra were recorded in transmission
geometry using a 57Co in rhodium foil source. The
source was driven at constant acceleration from 313
to +13 mm/s with a double ramp waveform. Spectra
were subsequently folded to eliminate the parabolic
background due to variation in the solid angle sub-
tended by the detector window about the source. The
resulting spectra consisted of 250 data points with a
background count of between 0.3 and 1.5U106 per
channel. The counting time was determined by the
properties of the sample under study (see later). The
velocity scale was calibrated with reference to the
spectrum of an K-iron foil at room temperature,
the center of the spectrum being taken as zero veloc-
ity. Freeze dried samples of tissue were packed into
10 mm diameter perspex sample holders. The thick-
ness of the sample was adjusted so that the 14.4 keV
Mo«ssbauer Q-rays were attenuated by approx. 1/e.
Sample temperatures were maintained at 78 K during
the spectral data acquisition using a liquid nitrogen
cryostat.
Each Mo«ssbauer spectrum was initially ¢tted with
a doublet and sextet of Lorentzian peaks using a sum
of squares minimization procedure. In some spectra,
a signal due to heme iron was detectable and as such
a second doublet was included in the ¢tting proce-
dure. The two peaks in each doublet were con-
strained to be of equal area and width while the ratio
of areas of the outer to middle to inner pairs of
peaks of the sextet were constrained to be in the ratio
3:2:1. The linewidths, center shift, and quadrupole
splitting of the doublet were allowed to vary freely
during the ¢t as were the linewidths, magnetic hyper-
¢ne-¢eld splitting, center shift, and quadrupole per-
turbation on the sextet. This ¢tting procedure yields
reproducible spectral parameters and doublet to sex-
tet area ratios for spectra with high signal to noise
ratios. However, for spectra with low sextet-signal to
noise ratios, this ¢tting procedure tends to give un-
reliable results.
Mean values for the Mo«ssbauer spectral parame-
ters of the sextet signal in the four spleen spectra
with the highest sextet-signal to noise ratio were
used as a standard with which to re¢t all of the
spleen tissue spectra. All of the spleen spectra were
re¢tted with a high-spin Fe(III) doublet, a heme dou-
blet where necessary, and the standard sextet. During
the ¢tting procedure, the linewidths, magnetic hyper-
¢ne-¢eld splitting, center shift, and quadrupole per-
turbation of the sextet were allowed to vary by up to
1 S.D. from the mean values derived from the four
spectra with the highest sextet-signal to noise ratios.
The area of the sextet was allowed to vary freely. In
this way the relative spectral area of the sextet in
spectra with very low sextet-signal to noise ratios
could be more reliably assessed assuming that the
Mo«ssbauer spectral parameters of the sextet do not
vary signi¢cantly from sample to sample.
In order to gauge the magnitude of the error in
measurement of the relative spectral area of the sex-
tet component in the spectra, the spectra were ana-
lyzed in terms of the total numbers of counts within
particular velocity regions of interest. Three regions
of interest were identi¢ed by inspection of the four
spleen spectra with the highest sextet-signal to noise
ratio. The three regions represent (i) velocity regions
where the Mo«ssbauer signal is negligible (i.e. back-
ground), (ii) velocity regions encompassing almost all
of the outer peaks of the sextet without encompass-
ing any signi¢cant intensity from other parts of the
spectrum, and (iii) the entire velocity range of the
spectrum. These regions of interest can be de¢ned
by four velocity boundaries which were found by
inspection to be v1 =39.0 mm/s, v2 =35.5 mm/s,
v3 = 6.2 mm/s, and v4 = 9.5 mm/s where region (i) is
v6 v1 or vs v4, region (ii) is v16 v6 v2 or
v36 v6 v4, and region (iii) is the entire velocity
scan of the spectrum (vmin6 v6 vmax). If ci is the
number of data channels in region i, Xi is the
total number of counts detected in region i, Bi is
the total number of counts expected in region i if
the intensity of the Mo«ssbauer signal were zero,
and Si = Bi3Xi (i.e. the number of counts ‘missing’
in region i due to the presence of the Mo«ssbauer
signal) then the fractional area of the spectrum in
the sextet is given by
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assuming that the ratio of areas of the outer to mid-
dle to inner pairs of lines in a sextet is 3:2:1 and that
any signal in region 2 is solely due to a sextet similar
to the ones observed in the spectra with high sextet-
signal to noise ratios. The error expression in Eq. 1 is
obtained by commutation of Poisson statistical er-
rors of counting in each region of interest.
Thus this method of analysis gives an indication of
both the relative spectral intensity of a sextet in the
Mo«ssbauer spectra of spleen tissues and the inherent
error on the measurement due to the Poisson statis-
tics of counting. This is particularly useful when the
signal to noise ratio is very low.
3. Results
Iron concentrations in the spleen samples were
measured using atomic absorption spectroscopy and
are shown in Table 1. A Kolmogorov-Smirnov (K-S)
test on the data did not indicate any signi¢cant dif-
ference between the distribution of iron concentra-
tions in the Thai L-thalassemia/Hb E spleens and
the Australian L-thalassemia spleens.
Mo«ssbauer spectra of the spleen samples were re-
corded with samples at 78 K. All spectra showed a
relatively intense central doublet (Fig. 1) with spec-
tral parameters (Table 2) indicative of paramagnetic
or superparamagnetic high-spin Fe(III). Many of the
spectra also clearly showed a sextet signal (Fig. 1b).
Some spectra showed an additional low intensity
doublet which could be attributed to heme iron. By
assuming equal recoil-free fractions for the di¡erent
iron atoms in the tissue at 78 K, the fraction of heme
iron in the samples was calculated thus enabling the
non-heme iron concentrations in the tissues to be
deduced (Table 1). Since the heme signal in each
spectrum was very small, if detected at all, the values
for the non-heme iron concentrations were not very
di¡erent from those for the total iron concentrations.
A K-S test on the data did not indicate any signi¢-
cant di¡erence between the distributions of non-
heme iron concentrations in the Thai L-thalassemia/
Hb E spleens and Australian L-thalassemia spleens.
Table 2 shows the mean values and standard de-
viations for the Mo«ssbauer spectral parameters of
the non-heme iron doublet signal for the Thai L-tha-
lassemia/Hb E and Australian L-thalassemia spleens.
Previously reported data for normal spleens are also
shown [16]. K-S tests on the distributions of spectral
parameters in each group showed signi¢cant di¡er-
ences between (i) the quadrupole splittings for the
Thai L-thalassemia/Hb E and the normal spleens
(K-S statistic = 1.00, P6 0.01), (ii) the quadrupole
splittings for the Australian L-thalassemia spleens
and the normal spleens (K-S statistic = 1.00,
P6 0.01), (iii) the center shifts for the pooled thalas-
semia spleens (Thai plus Australian) and the normal
spleens (K-S statistic = 0.52, P = 0.02). Di¡erences
were also identi¢ed, but with a lower degree of con-
¢dence, between the distributions of (iv) the center
shifts for the Thai L-thalassemia/Hb E spleens and
normal spleens (K-S statistic = 0.50, P = 0.07), (v) the
Table 1
Mean values and standard deviations (or ranges) for iron concentrations (mg Fe/g dry tissue), non-heme iron concentrations (mg Fe/g
dry tissue), and fractions, Fs, of the non-heme Mo«ssbauer spectral signal in the form of a sextet for human tissue samples
Tissue Iron concentration Non-heme iron concentration Fs
Thai L-thal/Hb E spleen (n = 12) 5.5 5.4 0.128
S.D. 1.7 1.8 0.035
Aus L-thal spleen (n = 7) 7.8 7.7 0.27
S.D. 6.0 6.0 0.12
Thai L-thal/Hb E liver (n = 4) 32 32 0.11
Range 18^43 18^43 0.08^0.14
Thai L-thal/Hb E pancreas (n = 3) 16 16 0.17
Range 12^20 12^20 0.12^0.27
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center shifts for the Australian L-thalassemia spleens
and the normal spleens (K-S statistic = 0.55,
P = 0.09), and (vi) the linewidths for the Australian
L-thalassemia spleens and normal spleens (K-S sta-
tistic = 0.58, P = 0.06).
In many of the spleen tissue Mo«ssbauer spectra the
sextet-signal to noise ratio was low and the free ¢t-
ting of Lorentzian peaks to the data often gave un-
reliable results due to peaks being ¢tted to the noise
rather than true signals. In order to measure more
reliably the fraction, s, of the Mo«ssbauer spectrum
made up by the sextet signal, it was assumed that the
parameters of the sextet signal were very similar for
all spleen samples so that a standard sextet with con-
strained parameters could be ¢tted to the data. The
parameters of the standard sextet were taken to be
the mean values of the spectral parameters of the
four spectra with the highest sextet-signal to noise
ratio (Table 3). All of the spleen spectra were then
re¢tted with a high-spin Fe(III) doublet, a heme dou-
blet where necessary, and the standard sextet. During
the ¢tting procedure, the linewidths, magnetic hyper-
¢ne-¢eld splitting, center shift, and quadrupole per-
turbation were allowed to vary by up to one stand-
ard deviation from the mean values derived from the
four spectra with the highest sextet-signal to noise
ratios. The sextet signal intensities as a fraction (Fs)
of the total non-heme iron Mo«ssbauer spectral signal
derived from this method of ¢tting are given in Table
1. The heme signal was typically less than 5% of the
Table 2
Mean values and standard deviations (or ranges) for Mo«ssbauer spectral parameters of the central doublet components of human tis-
sues at 78 K
Tissue N vEQ y
Thai L-thal/Hb E spleens (n = 12) 0.46 0.66 0.61
S.D. 0.02 0.03 0.06
Aus L-thal spleens (n = 7) 0.46 0.68 0.67
S.D. 0.03 0.03 0.08
Normal spleensa (n = 12) 0.39 0.51 0.56
S.D. 0.09 0.10 0.14
Thai L-thal/Hb E livers (n = 4) 0.48 0.66 0.58
Range 0.47^0.49 0.64^0.70 0.53^0.68
Normal liversa (n = 12) 0.45 0.60 0.64
S.D. 0.06 0.10 0.16
Thai L-thal/Hb E pancreas (n = 3) 0.47 0.64 0.58
Range 0.47^0.48 0.60^0.66 0.52^0.62
N is the center shift in mm/s, vEQ is the quadrupole splitting in mm/s and y is the full linewidth at half-height in mm/s.
aTaken from [16].
Fig. 1. Mo«ssbauer spectra of (a) a sample of Thai L-thalasse-
mia/Hb E spleen and (b) a sample of Australian L-thalassemia
spleen at 78 K. The size of the error bars on each data point is
given by kN where N is the number of Q-ray counts for that
data point. The solid curves are least squares ¢ts of the central
doublet and standard sextet components to the spectrum (see
Section 2). The dotted curves indicate the two spectral subcom-
ponents comprising the ¢t. (Heme signals were not detectable in
either of these two spectra.)
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total spectral area with the exception of two samples
that gave 14 and 20% respectively. Thus in general,
Fs was approximately equal to the fraction, s, of the
total Mo«ssbauer signal in the form of a sextet.
A K-S test on the distributions of Fs in the two
groups showed a signi¢cant di¡erence between the
two distributions (K-S statistic = 0.71, P = 0.01).
Fig. 2 shows a scatterplot of Fs against the non-
heme iron concentration for the tissue samples. Nei-
ther the data for the Thai L-thalassemia/Hb E nor
the data for the Australian L-thalassemia spleens
showed a signi¢cant correlation between Fs and the
iron concentration. However, when all of the spleen
data are taken together, there is a small (Spearman
rank-order correlation coe⁄cient of 0.46) but signi¢-
cant (P = 0.05) positive correlation between Fs and
non-heme iron concentration.
In order to obtain an approximate estimate of the
error on each measurement of Fs, each spectrum was
analyzed in terms of the total number of counts ac-
cumulated in three regions of the spectrum (see Sec-
tion 2) giving an alternative measure of s and an
estimate for the error (vs) on s. Fig. 3 shows a plot
of the calculated error on s for samples with di¡erent
Fs and non-heme iron concentrations. Although the
errors can be reduced to some extent by extending
the counting time in the experiment, there is a prac-
tical limit to the time for one measurement (approx.
1 week). The exponent of 1/2 in Eq. 1 results in
diminishing returns in error reduction for longer
counting times. The trends in Fig. 3 are as expected
with smaller errors for higher non-heme iron concen-
trations and larger Fs.
Fig. 4 shows the distribution of di¡erences (each
normalized to the calculated error, vs) in the meas-
Fig. 3. The calculated error, vs, on the fraction, s, of the Mo«ss-
bauer signal in sextet form against non-heme iron concentration
in the tissues and the fraction, Fs, of the non-heme Mo«ssbauer
signal in the form of sextet in each tissue.
Fig. 2. The fraction, Fs, of the non-heme Mo«ssbauer signal in
the form of sextet versus non-heme iron concentration in the
tissues. E, Thai L-thalassemia/Hb E spleen; R, Australian L-
thalassemia spleen; b, Thai L-thalassemia/Hb E liver; a, Thai
L-thalassemia/Hb E pancreas.
Table 3
Mean values and ranges for Mo«ssbauer spectral parameters of sextet components in thalassemic tissues at 78 K
Tissue N vEQ Bhf y
Spleen (n = 4) 0.47 30.21 47.0 0.86
Range 0.42^0.51 30.28 to 30.13 46.5^47.4 0.73^0.99
Liver (n = 4) 0.51 30.30 46.7 0.81
Range 0.48^0.56 30.34 to 30.27 46.5^47.0 0.60^1.09
Pancreas (n = 3) 0.43 30.10 46.7 0.86
Range 0.35^0.49 30.29 to 0.24 46.6^46.8 0.74^1.10
N is the center shift in mm/s, vEQ is the quadrupole perturbation, Bhf is the magnetic hyper¢ne-¢eld splitting in T, and y is the full
linewidth at half-height of the outer lines of the sextet in mm/s.
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urement of s between the two methods for all of the
tissues in the study. After rejecting one outlier with a
di¡erence of 4.7 vs, the distribution approximates
well to a normal distribution. The distribution has
a mean of 0.18 þ 0.13 with a standard deviation of
0.65. This indicates that vs is a reasonable estimate
for the random errors on the measurement of s and
hence Fs.
Iron concentrations (Table 1) and Mo«ssbauer
spectra were measured for four liver and three pan-
creas samples from Thai L-thalassemia/Hb E pa-
tients. Fitting doublets and sextets to the Mo«ssbauer
data gave mean spectral parameters as shown in Ta-
bles 2 and 3. Previously reported data are also given
for normal livers [16]. The spectra were also ¢tted
with the standard spleen sextet. Both methods gave
the same value for s within the experimental error,
vs. Values of Fs for the Thai L-thalassemia/Hb E
liver and pancreas samples are given in Table 1
and are plotted against the non-heme iron concen-
tration in Fig. 2.
4. Discussion
The thalassemic spleen samples in this study had
signi¢cantly higher total iron and non-heme iron
concentrations than those found for normal spleens.
This is consistent with ¢ndings of previous workers
[17,18]. Our measured values of 5.5 (S.D. 1.7) and
7.8 (S.D. 6.0) mg Fe/g dry tissue for the Thai L-
thalassemia/Hb E and Australian L-thalassemia
spleens respectively fall between 3.6 (S.D. 1.2) meas-
ured for 20 Thai L-thalassemia/Hb E spleens [17] and
10.4 (S.D. 5.8) measured for 7 Italian L-thalassemia
major spleens [18]. Interestingly, we did not detect a
signi¢cant di¡erence in either the total iron concen-
trations or the non-heme iron concentrations be-
tween the Thai L-thalassemia/Hb E spleens and the
Australian L-thalassemia spleens despite the fact that
the Australian patients are treated with regular blood
transfusions and chelation therapy.
The Mo«ssbauer spectra recorded for all of the tis-
sues in this study consisted of a central doublet char-
acteristic of high-spin Fe(III) superposed on a lower
intensity sextet, the sextet being due to magnetic hy-
per¢ne-¢eld splitting of the 57Fe nuclear energy levels
(Tables 2 and 3). Occasionally a second doublet that
could be attributed to heme iron was also present.
Similar central doublet and sextet signals have been
observed in previous reports of Mo«ssbauer spectra of
human tissues or extracts from human tissues [5,11^
16,19^27]. On the basis of these previous reports
these spectral components can be identi¢ed as being
due to polynuclear iron(III) oxyhydroxide deposits in
the tissue. This is consistent with the fact that the
predominant form of iron found in iron loaded tis-
sues is usually hemosiderin [7]. The doublet compo-
nent in the spectrum has parameters consistent with
(a) ferritin, (b) non-crystalline hemosiderin, (c) he-
mosiderin based on the structure of the mineral fer-
rihydrite, or (d) the doublet component associated
with hemosiderin based on the structure of the min-
eral goethite (the doublet component being due to
those hemosiderin particles with a smaller magnetic
anisotropy energy) [5,10,11]. As such it is not possi-
ble to unambiguously identify the source of this sig-
nal and the signal may be due to a combination of
the above forms of iron. However, the sextet compo-
nent in the spectrum can be identi¢ed as being due to
the presence of hemosiderin based on the structure of
the mineral goethite since this is the only form of
tissue iron deposit known to give a Mo«ssbauer spec-
tral sextet component with these parameters at 78 K
[12^14].
The observed di¡erences in the distributions of
Mo«ssbauer spectral parameters of the central doublet
between the di¡erent tissue groups are suggestive of
Fig. 4. Histogram showing the distribution of di¡erences (nor-
malized to the calculated vs) between the value of s measured
by the ¢tting of the standard sextet method and by the region
of interest method. The solid curve shows a ¢t of a Gaussian
curve to the distribution.
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di¡erences in the structure of the iron oxide particles
within the tissues. For example, the quadrupole split-
tings of Mo«ssbauer spectral doublets of ferrihydrite
are negatively correlated with the degree of crystal-
linity such that the poorer the crystallinity, the larger
the quadrupole splitting [28]. Thus, the generally
larger quadrupole splittings of the doublets for the
thalassemic spleens compared with those for the nor-
mal spleens may possibly be due to the presence of
ferrihydrite with a lower degree of crystallinity. How-
ever, the di¡erence should be treated with caution
since the normal spleen Mo«ssbauer spectra tended
to have a lower signal to noise ratio and a larger
fraction of heme signal and hence the di¡erences
may be, in part, an artefact of the curve ¢tting pro-
cedure [16].
Fig. 3 indicates that for tissue samples with non-
heme iron concentrations less than approx. 1 mg Fe/
g dry weight tissue, the limit of detection of Fs by
Mo«ssbauer spectroscopy is FsW0.10. Since normal
spleens typically have iron concentrations of about
1 mg Fe/g dry weight tissue [16,29] and no sextet has
been detected in the Mo«ssbauer spectra of normal
spleens at 78 K [16] using conventional methods of
spectral curve ¢tting, this implies that Fs must be less
than 0.10 in normal tissues, if it is present at all.
However, we have con¢dently detected sextet signals
in the thalassemic spleen samples with signi¢cantly
higher values of Fs being measured in the Australian
L-thalassemia spleens than the Thai L-thalassemia/
Hb E spleens (Table 1 and Fig. 2). This indicates
that the fraction of non-heme iron in the goethite-
like form is signi¢cantly greater in the Australian L-
thalassemia spleens than in the Thai L-thalassemia/
Hb E spleens. The small positive correlation of Fs
with non-heme iron concentration in the spleen tis-
sues suggests that the fraction of non-heme iron in
the goethite-like form may be weakly associated with
tissue non-heme iron concentrations.
The lower number of samples of liver and pan-
creas available for study does not enable a rigorous
statistical analysis. However, the Mo«ssbauer spectra
were qualitatively similar to those obtained from the
spleen samples (Tables 2 and 3) while the non-heme
iron concentrations were generally higher than those
for the spleen samples (Table 1 and Fig. 2). The low
values of Fs measured for the liver samples, despite
their higher non-heme iron concentrations, implies
that non-heme iron concentration is not the only
factor a¡ecting the fraction of non-heme iron in
the goethite-like form in human tissues. Cell type
could also play a role.
There could be several reasons for the di¡erence in
chemical speciation of spleen iron between the two
groups of thalassemia patients studied including (a)
the di¡erent genotypes of the two groups, (b) the
e¡ect of blood transfusions, (c) the e¡ect of chelation
therapy, (d) di¡erences in diet. We are currently
undertaking experiments on animal systems in order
to identify which factors may have the most in£uence
on the speciation. The fact that there is di¡erent
chemical speciation of iron in tissues between di¡er-
ent identi¢able groups of patients has implications
for the treatment and management of iron overload
diseases. The reactivities of the di¡erent iron oxide
forms are expected to be di¡erent. Ferrihydrite is less
stable than goethite. Its solubility product
(Fe3)W(OH)3 is about 10338 to 10339 compared
with 10342 to 10344 for goethite [30]. Although the
goethite-like form of hemosiderin is likely to be more
soluble than goethite itself, hemosiderin from trans-
fusional iron loaded patients has been shown to re-
lease iron less readily than the ferrihydrite cores of
ferritin when exposed to various chelators [31^33].
Thus the ferrihydrite form of hemosiderin may be
more toxic to cells than the goethite-like form on
an atom for atom basis because of its higher solubil-
ity. On the other hand, it should be easier to chelate
and remove from the body than the goethite-like
form. This may partly explain why the Australian
patients in our study had higher fractions of their
non-heme spleen iron in the goethite-like form.
More of the ferrihydrite form may have been re-
moved by the chelation therapy, the remaining
deposits thus being enriched in the goethite-like
form.
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